TraceLink

TraceLink offers a digital network platform that provides end-to-end supply chain orchestration solutions for the healthcare and life sciences industry. The platform enables the seamless exchange of information among partners related to supply chain planning, external manufacturing, logistics, clinical supply, and more, enabling rapid onboarding, management, and integration of partners' systems and business processes. This approach enhances supply chain visibility and prevents counterfeit products from entering the market. As of September 2024, the platform connected over 291,000+ authenticated network members across the healthcare and life sciences supply chain.

The company also uses its Opus platform to provide users with advanced data-sharing capabilities, application development tools, and an open ecosystem for supply chain partners to build custom applications. It focuses on transforming supply chain operations by enabling greater agility and efficiency. In addition, it offers serialized product intelligence (SPI) and compliance and serialization solutions to help pharmaceutical companies comply with regulatory requirements, including the US Drug Supply Chain Security Act (DSCSA) and the European Falsified Medicines Directive (FMD). In September 2024, the company announced the Magnum release of its Opus platform, which had several key features, including the Opus Solution Environment (OSE) for no-code configuration of multi-enterprise supply chain solutions, a Universal Integration Platform for interoperable integration formats, and the Multienterprise Information Network Tower (MINT) to orchestrate various supply chain processes. It also includes integrated supply chain reports, dashboards, and an AI copilot called "Amadeus”. In September 2024, the company also launched Opus Reports and Dashboards as part of its Opus Platform Magnum release. This new feature allows users to monitor supply chain performance metrics in real-time and is accessible through a Microsoft or Azure Active Directory account.

In August 2009, TraceLink acquired SupplyScape Corporation, a provider of product traceability solutions. This acquisition bolstered TraceLink's track-and-trace offerings, enabling better security and compliance in the pharmaceutical supply chain. In August 2017, the company also acquired ROC IT Solutions, a company specializing in intelligent Edge data capture for serialized product inventory in the pharmaceutical supply chain. This acquisition allowed TraceLink to integrate ROC IT's EdgeTRAC solution into its existing serialization software, enhancing its capabilities for managing warehouse product inventory and serialized product data.

Key customers and partnerships

TraceLink serves a wide range of customers across the healthcare and life sciences supply chain, including manufacturers, wholesalers, distributors, and pharmacies. Notable customers included Boston Medical Center, Merz Therapeutics, and Sentara Health. As of September 2024, TraceLink had processed over 454 million transactions and had 1,600+ customers across the supply chain.

In May 2024, TraceLink partnered with RSM, a leading provider of assurance, tax, and consulting services, to accelerate the digital transformation of the global healthcare and life sciences industries. This collaboration aimed to provide a streamlined "single-vendor approach" for healthcare and life sciences leaders to acquire real-time supply chain information needed to accelerate new products to market, reduce manufacturing costs and working capital requirements, and optimize the efficiency of global, multi-enterprise workforces.

In June 2023, TraceLink announced a partnership with Value Drug Company, a leader in wholesale distribution and retail/specialty pharmacy services, to provide a comprehensive commercial solution and services program for independent pharmacies to meet the Drug Supply Chain Security Act (DSCSA) regulatory requirements.